Our Medtech Payment Summit is a unique event that discusses various payment models and reimbursement pathways for medical devices, diagnostics and digital health products. Featuring interactive panels with medtech leaders and hospital partners, the Summit will help to clarify the payment pathways for your product and build relationships among industry peers.
Kicking off the day with an optional "Payment 101 Crash Course," the agenda will include presentations and panel discussions on various payment models featuring real-world case studies, as well as topics such as, the evolving political and legal landscape around payment policy and recent updates including the Supreme Court's recent ruling on the Chevron Deference.
This is a great program to garner actionable information about identifying and securing relevant payment pathways for your products, as well as a chance to get your questions answered by our experts.
We will provide a Uniform Certificate of Attendance for in-person attendees should you wish to apply for continuing education units (CEU).
AGENDA
Rujul Desai, Partner, Covington & Burling
Michelle Fox, Corporate Vice President and Chief Medical Officer, Teleflex
Stephanie Wimmer, Global Vice President, Health Economics, Market Access, and Reimbursement (HEMAR), Philips
Head of Population Health, Best Buy Health
Ira Goldman, VP of Government Affairs, Lantheus
Yajuan Lu, J.D., Director, Corporate Health Policy & Reimbursement, Boston Scientific
What’s Next: Will Congress Act on Payment Policy after TCET?
In August, CMS released its long-awaited final guidance on the Transitioning Coverage of Emerging Technologies or TCET, capping an eight-year journey from the first introduction of a breakthrough pathway for medical devices to receive transitional coverage. However, the limited scope of TCET leaves much to be desired and it is not the game changer the device industry has been hoping for. Congress has a chance to improve the program with HR 1691, the Ensuring Patient Access to Critical Breakthrough Products Act of 2023. With just three months left in the session, and a national election ahead, will any action be taken on this critical legislation? Hear from experts on what to watch out for in this critical debate.
Patrick Cunningham, Founder and Principal, Re-architect Health LLC
Michael Ferguson, Ph.D., Vice President, Global Healthcare Economics and Reimbursement, AtriCure
Melissa Schooley, VP, Global HEMA & GA, Abiomed, part of JNJ MedTech
SPEAKERS
With over 25 years of experience in healthcare, Stacey has held leadership roles in both hospital settings and the medical device industry. Previously, she served as the Revenue Director at a large academic medical center in Boston and Vice President of a hospital system encompassing community and academic hospitals.
At a medical device company focused on cardiovascular care, Stacey led the global reimbursement strategy. She collaborated with federal agencies to establish new Diagnosis Related Groups (DRGs) as well as successfully transitioned their technology into existing DRGs that better reflected the cost of care for critically ill patients.
Stacey holds a Master's degree in Organizational Leadership, is a certified coder, and is a Fellow of the Advisory Board Company. Her career has been dedicated to advancing patient care through sustainable financial models and innovative solutions.
Patrick CunninghamFounder and PrincipalRe-architect Health LLC
Patrick is the Founder and Principal at Re-architect Health LLC, a firm which provides consulting services on the architecture of virtual care delivery models, including the formation, reimbursement, operation, and scalability of technology-enabled specialty service lines. Current clients include pharmaceutical manufacturers, medical device manufacturers, and venture-backed start-ups building virtual clinics for chronic diseases, neurology, cardiology, and women’s health among others.
Previously, Patrick was an early employee at Onduo, a joint venture between Sanofi and Verily Life Sciences, and was directly responsible for building and scaling the first nationwide virtual diabetes clinic as well as value-based contracting with commercial and government payers.
Patrick earned a BS in Chemistry from Bates College and an MBA from the Tuck School of Business at Dartmouth College.
Rujul DesaiPartnerCovington & Burling
Rujul Desai is a Partner in Covington's Washington, DC office, where he is a member of the Health Care and Digital Health Practice Groups. He advises life science clients on novel contracting, compliance, and policy issues related to pricing, market access, and reimbursement for medical products. He brings decades of experience advising on the complex system of federal and state laws governing the healthcare industry. Rujul regularly advises drug, biologic, device, and diagnostic manufacturers on legal risk assessments involving new product launches, government and commercial pricing, PBM and payer formulary access, value-based contracting, GPO and supplier arrangements, patient access and hub services, affordability programs, e-prescribing, telehealth, digital health, and the use of health economic data and modeling.
Nick DoucetteManager, Health Policy & ReimbursementNovocure
Nick has developed a broad knowledge of the Reimbursement workflow in his five years with Novocure. In his most recent role, he focused on strategy and scaling opportunities including projects that led to the implementation of projects that created efficiencies supporting patients. Nick manages the relationships and coverage policy with the Department of Veterans Affairs and State Medicaid Agencies. He lives in New Hampshire with his wife, two girls, and Golden Retriever. In his free time, he enjoys teaching his girls to golf, running, and spending time by the water with family.
Michael FergusonVice President of Healthcare Economics and ReimbursementAtriCure
Michael is the Vice President of Healthcare Economics and Reimbursement for AtriCure, a surgical medical device company focused on treatment of atrial fibrillation. Michael has responsibility for overall reimbursement, health economics, and market access strategy. Some of his groups work and collaboration with specialty societies has resulted in new CPT and MS-DRG payment codes. Prior to his role at AtriCure he held leadership positions at Boston Scientific, Philips Healthcare, and Medtronic.
He earned his PhD at the University Florida in Applied Physiology.
Ira N. Goldman
Vice President, Global Public Policy and Government Relations
Lantheus Holdings
Mr. Goldman is responsible for development and execution of Lantheus’s strategy and actions for public and healthcare policy, including legislative strategy and interactions with the U.S. Congress as well as relationships with Executive Branch agencies.He coordinates Lantheus’s involvement with trade associations, business and regional advocacy groups and medical societies. He also interacts with U.S. and foreign governments and international organizations regarding medical isotope production and supply matters.
Mr Goldman earned a Master of Arts in International Affairs (with distinction) from the Johns Hopkins University Nitze School of Advanced International Studies in Washington DC in 1980, including study at the Johns Hopkins Centre for European Studies in Bologna, Italy (1978-1979). Mr Goldman earned a Bachelor of Arts (with honours) in History and was Phi Beta Kappa at Trinity College, Hartford, Connecticut in 1978.
Mr. Hill brings 25+ years of Business Value & Healthcare Transformation for health systems, health plans, and innovative healthcare companies. Prior to joining EPAM, Mike served numerous consulting and leadership roles focused on business transformation and optimizing healthcare economic and clinical outcomes through deployment of technology, data, predictive analytics, and payer and provider collaboration.
Selected prior client organization work includes national and regional payers including Optum/UnitedHealth Group, Aetna/CVS, Blue Cross Blue Shield Plans, and others; large academic health systems, and innovative technology and value-based care companies specific to the Medicare Advantage business.
Dr. Liz Kwo is a transformative physician entrepreneur, payer executive, and instructor at Harvard Medical School. Dr. Liz Kwo is currently the Chief Commercial Officer of Everly Health, a digital health company at the forefront of the $300 billion virtual diagnostics-driven care industry. With a proven track record of building companies for two decades, Dr. Kwo authored “DIGITAL MD: Revolutionizing the Future of Care” and served as Deputy Chief Clinical Officer for Elevance (NYSE: ELV) modernizing care for 43 million Americans in Medicare, Medicaid, and Commercial populations. Prior to Elevance, Dr. Kwo started several venture backed companies as the CEO and co-founder of InfiniteMD (acquired by Consumer Medical), and President and co-founder of New Pathway Education and Technology Group (acquired by EIC Education). Dr. Kwo is on the Board of Directors of Asensus Surgical (NYSE AMERICAN: ASXC), Walmart Mexico and Central America (Mexican Stock Exchange/BMV: WALMEX), BlueWind Medical and ChroniSense. Dr. Kwo continues to see patients in urgent care at Cambridge Health Alliance Hospital, teach residents as a faculty lecturer at Harvard Medical School, and is board certified in Preventive Care and Occupational Medicine. She earned a BA in Human Biology from Stanford University, MD from Harvard Medical School, MBA from Harvard Business School, and an MPH from Harvard T.H. Chan School of Public Health.
Charlie Miceli Currently serves as Strategic Advisor for Finance at University of Vermont Health Network. Charlie served at University of Vermont Health Network Chief Supply Chain Officer through March 2024.
Charlie has also served as Interim CEO for both Inter-Lakes Heath in 2010-2011 and 2014 as well as CIO for One Care Vermont and Deputy CIO and VP Pharmacy for UVM Medical Center. Prior Supply Chain roles include Chicago (Northwestern, Loyola and Univ of Chicago) and Boston (Partners Healthcare and Newton Wellesley) as well as consultancy for BD Health Care Consulting and Services.
In October 2023 he was inducted into the Bellwether League Foundation Healthcare Supply Chain Hall of Fame. He earned a B.A. in Psychology from Notre Dame.
Melissa manages Abiomed US and Global health economics and market access strategy consistent with the core principles of recovering hearts and saving lives. She specializes in the intersection of reimbursement, health economics, policy, and government advocacy. She has led and works closely with our physician partners and patient advocates to support coverage, coding, and payment for new technologies. She has held leadership roles in payment and advocacy within AdvaMed and has served on the steering committee and advisory roles for the Medical Device Innovation Consortium (MDIC). Melissa has over 25 years of market access and reimbursement experience, most recently working for Medtronic. She worked on Capitol Hill for the Senate Judiciary Committee and has a law degree from American University and degree in Political Science and Business from JMU. Melissa also serves on the Virgina Tech Fralin Biomedical Research Institute Board. Her career has been focused on advancing innovation and supporting patient access to care.
Stephanie currently leads the Global Health Economics, Market Access, and Reimbursement (HEMAR) organization for Philips, championing patient access for Philips’s $18B product portfolio.
SPONSORS
$175 for member in-person tickets$225 for non-member in person tickets
Save $30 with early bird rates through Sept. 6!
Have a login? Login Now
{{vm.loginInfo.errorMessage}}
Create an Account
Forgot your Username or Password?
Register as Guest
Address
Phone
{{slot.Name}}
{{ vm.EventInfo.EventSettings.NoShowPolicy }}